You are here: Industry Insights > catalyst

News List

Catalyst Receives Fast Track Designation for Hemophilia Episodic Bleeding Treatment americanpharmaceuticalreview
December 03, 2020
Catalyst Biosciences announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Marzeptacog alfa (activated) – or MarzAA, the Company’s subcutaneously (SQ) administered next-generation engineered coagulation ...
Catalyst Files Patent Infringement Actions against Jacobus, PantherRx americanpharmaceuticalreview
October 23, 2020
Catalyst Pharmaceuticals has filed a lawsuit in the U.S. District Court for New Jersey against Jacobus Pharmaceuticals and a lawsuit in the U.S. District Court for the Western District of Pennsylvania against PantherRx Rare for infringement of ...
Catalyst Announces Issuance of U.S. Patent for Firdapse americanpharmaceuticalreview
October 10, 2020
Catalyst Pharmaceuticals announced the United States Patent and Trademark Office (USPTO) has issued a new U.S. patent to Catalyst Pharmaceuticals for Firdapse® (amifampridine), U.S. Patent No. 10,793,893, Methods of Administering 3,4-Diaminopyridine ...
Single catalyst could simplify biomanufacturing, lowering costs europeanpharmaceuticalreview
March 11, 2020
Chemists have synthesised a single catalyst, able to perform multistep cascades of chemical reactions to produce a pharmaceutical product.
Technique to synthesise aziridines developed by researchers europeanpharmaceuticalreview
March 03, 2020
Eliminating expensive catalysts, researchers have shown it is possible to transfer nitrogen atoms to unactivated olefins for the production of aziridines.
Catalyst Biosciences Announces Global License, Collaboration Agreement americanpharmaceuticalreview
December 24, 2019
Catalyst Biosciences has entered into a global license and collaboration agreement with Biogen for the development and commercialization of pegylated CB 2782 (CB 2782-PEG) ...
US Food and Drug Administration sued over Ruzurgi drug approval europeanpharmaceuticalreview
June 20, 2019
Catalyst Pharmaceuticals Inc has sued the FDA to challenge the recent approval of a lower-cost rival drug.
Diversifying drug development with a metal catalyst europeanpharmaceuticalreview
April 10, 2019
Researchers have outlined a method of formulating drug-like aliphatic and aromatic carbon-hydrogen scaffolds into drugs using a metal catalyst…
Patient advocate urges BIO to boot Catalyst over its $375K Firdapse price fiercepharma
March 08, 2019
Sen. Bernie Sanders, I-Vt., isn’t the only pharma critic shining a light on relatively unknown drugmaker Catalyst Pharmaceuticals.
Sanders escalates fight with Catalyst, asking FDA to allow unbranded copies of $375K Firdapse fiercepharma
March 03, 2019
After a seemingly vain attempt to appeal to Catalyst Pharmaceuticals’ conscience, Sen. Bernie Sanders, I-Vt., has turned to the FDA, asking the agency to allow cheaper, unapproved versions of Catalyst’ Firdapse to be distributed as they had been over the

Previous page 1 2 Next page